Furthermore, we had no available insulin data for the assessment of IR, yet an additional adjustment for fatty liver may compensate for this limitation because fatty liver is a well-known risk factor for T2D with mechanistic involvement of systemic inflammation, hepatic IR, oxidative stress, and lipid metabolism. The gene discussed is INS; the disease is type 2 diabetes mellitus.